Published in Database (Oxford) on April 04, 2014
iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines. Hum Vaccin Immunother (2015) 0.87
HPVbase--a knowledgebase of viral integrations, methylation patterns and microRNAs aberrant expression: As potential biomarkers for Human papillomaviruses mediated carcinomas. Sci Rep (2015) 0.80
FluKB: A Knowledge-Based System for Influenza Vaccine Target Discovery and Analysis of the Immunological Properties of Influenza Viruses. J Immunol Res (2015) 0.79
αβ TCR-mediated recognition: relevance to tumor-antigen discovery and cancer immunotherapy. Cancer Immunol Res (2015) 0.78
Forward Vaccinology: CTL Targeting Based upon Physical Detection of HLA-Bound Peptides. Front Immunol (2014) 0.77
Big data analytics in immunology: a knowledge-based approach. Biomed Res Int (2014) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res (2002) 47.62
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res (2009) 19.70
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol (2010) 9.86
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28
The immune epitope database 2.0. Nucleic Acids Res (2009) 6.07
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med (2009) 5.79
Global burden of human papillomavirus and related diseases. Vaccine (2012) 5.48
NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics (2008) 3.59
Immune responses to human papillomavirus. Vaccine (2006) 2.37
Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol (2008) 2.30
Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics (2008) 2.17
RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol (2009) 2.06
Cross-roads in the classification of papillomaviruses. Virology (2013) 1.87
Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol (2004) 1.81
NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res (2010) 1.78
The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res (2012) 1.75
Updating the natural history of human papillomavirus and anogenital cancers. Vaccine (2012) 1.65
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial. Eur J Cancer (1999) 1.44
Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil). Drugs (2006) 1.27
Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix]. Drugs (2008) 1.23
Clinical trials of human papillomavirus vaccines and beyond. Nat Rev Clin Oncol (2013) 1.11
Therapy of human papillomavirus-related disease. Vaccine (2012) 1.11
Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis. J Biosci (2009) 1.06
A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers. J Biol Chem (2010) 1.00
Molecular detection of targeted major histocompatibility complex I-bound peptides using a probabilistic measure and nanospray MS3 on a hybrid quadrupole-linear ion trap. Anal Chem (2010) 0.96
Concept and application of a computational vaccinology workflow. Immunome Res (2010) 0.93
Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens. Front Immunol (2011) 0.86
FLAVIdB: A data mining system for knowledge discovery in flaviviruses with direct applications in immunology and vaccinology. Immunome Res (2011) 0.84
The Human Papillomavirus Database. J Biomed Sci (1995) 0.83
hpvPDB: An Online Proteome Reserve for Human Papillomavirus. Genomics Inform (2013) 0.78
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science (2002) 4.02
HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity (2008) 3.01
Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics (2004) 2.49
Prediction of MHC class I binding peptides using profile motifs. Hum Immunol (2002) 2.43
The alphabeta T cell receptor is an anisotropic mechanosensor. J Biol Chem (2009) 2.41
Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol (2008) 2.30
Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics (2008) 2.17
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol (2002) 2.14
MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides. Nucleic Acids Res (2005) 2.05
Developmental bias in cleavage-stage mouse blastomeres. Curr Biol (2012) 1.98
Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol (2003) 1.88
Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS One (2010) 1.87
A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol (2008) 1.86
Dragon Promoter Finder: recognition of vertebrate RNA polymerase II promoters. Bioinformatics (2002) 1.85
Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface. Proc Natl Acad Sci U S A (2009) 1.79
Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS One (2007) 1.72
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. Int Immunol (2002) 1.69
Identification of human-to-human transmissibility factors in PB2 proteins of influenza A by large-scale mutual information analysis. BMC Bioinformatics (2008) 1.61
Methods for prediction of peptide binding to MHC molecules: a comparative study. Mol Med (2002) 1.61
CD8 alpha alpha homodimer expression and role in CD8 T cell memory generation during influenza virus A infection in mice. Eur J Immunol (2005) 1.56
Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients. FASEB J (2005) 1.50
Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction. J Clin Invest (2005) 1.50
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. Nat Biotechnol (2015) 1.47
Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies. AIDS Res Hum Retroviruses (2005) 1.44
Genome-wide characterization of a viral cytotoxic T lymphocyte epitope repertoire. J Biol Chem (2003) 1.38
Solution structure of the CD3epsilondelta ectodomain and comparison with CD3epsilongamma as a basis for modeling T cell receptor topology and signaling. Proc Natl Acad Sci U S A (2004) 1.33
Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules. J Biosci Bioeng (2002) 1.31
PVS: a web server for protein sequence variability analysis tuned to facilitate conserved epitope discovery. Nucleic Acids Res (2008) 1.30
A systematic bioinformatics approach for selection of epitope-based vaccine targets. Cell Immunol (2007) 1.30
Sialic acid capping of CD8beta core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction. J Biol Chem (2002) 1.29
Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization. Nat Struct Mol Biol (2011) 1.29
PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla. Immunity (2008) 1.27
Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity. J Virol (2009) 1.27
The crystal structure of a TL/CD8alphaalpha complex at 2.1 A resolution: implications for modulation of T cell activation and memory. Immunity (2003) 1.25
Transcriptionally abundant major histocompatibility complex class I alleles are fundamental to nonhuman primate simian immunodeficiency virus-specific CD8+ T cell responses. J Virol (2011) 1.24
Conservation and variability of dengue virus proteins: implications for vaccine design. PLoS Negl Trop Dis (2008) 1.23
The structural basis of αβ T-lineage immune recognition: TCR docking topologies, mechanotransduction, and co-receptor function. Immunol Rev (2012) 1.20
PREDBALB/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse. Nucleic Acids Res (2005) 1.20
ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization. Brief Bioinform (2009) 1.19
Supporting the curation of biological databases with reusable text mining. Genome Inform (2005) 1.18
Machine learning competition in immunology - Prediction of HLA class I binding peptides. J Immunol Methods (2011) 1.18
ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale. Philos Trans A Math Phys Eng Sci (2010) 1.16
Prediction of peptide-MHC binding using profiles. Methods Mol Biol (2007) 1.16
Prediction of methylated CpGs in DNA sequences using a support vector machine. FEBS Lett (2005) 1.16
One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma. J Immunol (2005) 1.15
Computer model for recognition of functional transcription start sites in RNA polymerase II promoters of vertebrates. J Mol Graph Model (2003) 1.15
SCORPION2: a database for structure-function analysis of scorpion toxins. Toxicon (2006) 1.14
EPIMHC: a curated database of MHC-binding peptides for customized computational vaccinology. Bioinformatics (2005) 1.14
PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands. Nucleic Acids Res (2005) 1.14
Combining cellular automata and Lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition. J Immunol Methods (2011) 1.14
NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells. Cancer Res (2002) 1.13
Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission. AIDS (2013) 1.13
Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state. Vaccine (2006) 1.12
Ultra-high resolution HLA genotyping and allele discovery by highly multiplexed cDNA amplicon pyrosequencing. BMC Genomics (2012) 1.12
Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies. J Biol Chem (2004) 1.11
Prediction of HLA-DQ3.2beta ligands: evidence of multiple registers in class II binding peptides. Bioinformatics (2006) 1.10
Mimotope vaccination--from allergy to cancer. Expert Opin Biol Ther (2009) 1.10
CysView: protein classification based on cysteine pairing patterns. Nucleic Acids Res (2004) 1.10
Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery. Biomaterials (2011) 1.10
Definition of MHC supertypes through clustering of MHC peptide-binding repertoires. Methods Mol Biol (2007) 1.09
Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion. Clin Cancer Res (2010) 1.09
Structural basis of T cell recognition of peptides bound to MHC molecules. Mol Immunol (2002) 1.08
Pillars article: Separation of functional subsets of human T cells by a monoclonal antibody. Proc. Natl. Acad. Sci. 1979. 76: 4061-4065. J Immunol (2013) 1.08
Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells. Cancer Res (2010) 1.08
FIMM, a database of functional molecular immunology: update 2002. Nucleic Acids Res (2002) 1.06
Pillars article: Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979. 206: 347-349. J Immunol (2013) 1.06
Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms. BMC Bioinformatics (2007) 1.05
Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice. Proc Natl Acad Sci U S A (2008) 1.04
Peptide-induced negative selection of thymocytes activates transcription of an NF-kappa B inhibitor. Mol Cell (2002) 1.04
Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens. Cancer Res (2010) 1.04
Distinctive CD3 heterodimeric ectodomain topologies maximize antigen-triggered activation of alpha beta T cell receptors. J Immunol (2010) 1.03
Computational resources for high-dimensional immune analysis from the Human Immunology Project Consortium. Nat Biotechnol (2014) 1.02
CTL recognition of a protective immunodominant influenza A virus nucleoprotein epitope utilizes a highly restricted Vbeta but diverse Valpha repertoire: functional and structural implications. J Mol Biol (2007) 1.01
TCR Mechanobiology: Torques and Tunable Structures Linked to Early T Cell Signaling. Front Immunol (2012) 1.01
Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells. Proc Natl Acad Sci U S A (2010) 1.01
Structural and functional evidence that Nck interaction with CD3epsilon regulates T-cell receptor activity. J Mol Biol (2008) 1.00
Neural models for predicting viral vaccine targets. J Bioinform Comput Biol (2005) 1.00
In vivo selection of a TCR Vbeta repertoire directed against an immunodominant influenza virus CTL epitope. Int Immunol (2004) 1.00
A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers. J Biol Chem (2010) 1.00
Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance. J Mol Biol (2004) 1.00
Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Cell Immunol (2004) 0.99
SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens. Virology (2006) 0.99
Prediction of supertype-specific HLA class I binding peptides using support vector machines. J Immunol Methods (2007) 0.98
PRED(TAP): a system for prediction of peptide binding to the human transporter associated with antigen processing. Immunome Res (2006) 0.98
Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms. Proc Natl Acad Sci U S A (2004) 0.98
Computational immunology: The coming of age. Immunol Cell Biol (2002) 0.98
MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles. J Immunol Methods (2010) 0.98